GlaxoSmithKline names Emma Walmsley as chief executive www.bbc.com
GlaxoSmithKline has chosen Emma Walmsley, its current head of consumer healthcare, as its new chief executive.
Ms Walmsley, who joined the UK's biggest drugmaker in 2010 from L'Oreal, will replace Andrew Witty next year.
Mr Witty had previously announced he would retire in March 2017.
GSK chairman Philip Hampton said there had been "a very thorough and rigorous global selection process" for the role, adding that Ms Walmsley was "an outstanding leader".
Ms Walmsley will be the drugs giant's first female chief executive, and one of only a handful of women in FTSE 100 chief executive roles.
"I am delighted and honoured to be appointed GSK's next CEO," Ms Walmsley said in a statement.
"I'm looking forward to working with Andrew and other leaders over the next few months to ensure a smooth handover and to develop plans for 2017 and beyond."
Published Date:2016-09-20